Authors
Jiansong Han, Xu Li, Xu Zhou, Yuhan Zhang
Published in
Tissue engineering. Part B, Reviews. Pages 19373368261506151. Nov 18, 2026. Epub Nov 18, 2026.
Abstract
Bladder cancer therapy faces significant challenges due to rapid drug clearance, poor urothelial penetration, and heterogeneous tumor distribution. Hydrogel-based platforms offer a versatile solution by enhancing intravesical drug retention, enabling controlled release, and supporting multifunctional interventions. These hydrogels can be engineered as mucoadhesive, thermosensitive, or field-responsive systems for intravesical delivery. Hydrogel-based immunotherapy further reshapes the tumor microenvironment, promoting local immune activation while minimizing systemic toxicity. Advanced designs incorporate tumor-responsive triggers, active transport, metabolic modulation, and extracellular matrix-targeted imaging to enable precision-guided therapy. Despite promising preclinical outcomes, translation to clinical practice requires addressing retention, safety, catheter compatibility, immunological effects, and regulatory considerations. Overall, hydrogel-based strategies represent a transformative approach for personalized, minimally invasive bladder cancer treatment, integrating chemotherapy, immunomodulation, and precision-guided interventions.
PMID:
43046810
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0